Show simple item record

dc.contributor.authorKulke, M
dc.contributor.authorHörsch, D
dc.contributor.authorCaplin, M
dc.contributor.authorAnthony, L
dc.contributor.authorBergsland, E
dc.contributor.authorOberg, K
dc.contributor.authorWelin, S
dc.contributor.authorWarner, R
dc.contributor.authorBohas, C
dc.contributor.authorKunz, P
dc.contributor.authorGrande, E
dc.contributor.authorValle, Juan W
dc.contributor.authorLapuerta, P
dc.contributor.authorBanks, P
dc.contributor.authorJackson, S
dc.contributor.authorJiang, W
dc.contributor.authorBiran, T
dc.contributor.authorPavel, M
dc.date.accessioned2017-04-19T17:04:41Z
dc.date.available2017-04-19T17:04:41Z
dc.date.issued2016-10-01
dc.identifier.citationIntegrated placebo-controlled safety analysis from clinical studies of telotristat ethyl for the treatment of carcinoid syndrome. 2016, 27(suppl_6):422PD Annals of Oncologyen
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.doi10.1093/annonc/mdw369.07
dc.identifier.urihttp://hdl.handle.net/10541/620257
dc.language.isoenen
dc.relation.urlhttps://academic.oup.com/annonc/article/2799161/Integrateden
dc.rightsArchived with thanks to Annals of Oncologyen
dc.titleIntegrated placebo-controlled safety analysis from clinical studies of telotristat ethyl for the treatment of carcinoid syndrome.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMedical Oncology, Dana-Farber Cancer Institute, Bostonen
dc.identifier.journalAnnals of Oncologyen


This item appears in the following Collection(s)

Show simple item record